Click here for CIT NUSLive webcast!
Speaker :
|
Assoc. Prof. Lee Chee Wee,
Founder of Lynk Biotechnologies Pte Ltd |
|
Date: |
8 July 2004 (Thursday) |
Time: |
6.00pm - 7.30pm |
Seminars organised by
the Entrepreneurship
Centre are now on the
CIT NUSLive website |
Venue: |
LT 7A, NUS Faculty of Engineering
(Pls click on "LT 7A, NUS Faculty of Engineering" on the campus map to to locate the LT.) |
Driving and Parking: |
Enter Engineering Drive 1 by Clementi Road. The nearest carpark is just next to Engineering Auditorium. The next nearest car park is next to Kent Vale. |
Abstract
The focus of the seminar is to share with the audience how Lynk Biotechnologies Pte Ltd, an NUS spin-off biotech company founded in Feb 2000, had evolved over the past 4 years, how it was able to survive the global economic recession with little external funding, and how it had created a business model that "might" work for Lynk in an extremely difficult and tightly regulated industry situated in a country with small domestic market. Briefly, Lynk had undergone various stages of evolution, from the model of "Growth" to "Survival", from the model of "Creator" to "User", and finally from the model of "Entrepreneurial" to "Innopreneurial". This evolution of Lynk business model(s) will be illustrated through its highly successful products such as BiolynTM Hair Serum/Shampoo (for hair loss market) and MediLynkTM Transdermal Glucosamine cream (for arthritis market).
About the Speaker
Lynk Biotechnologies Pte Ltd is a National University of Singapore (NUS) spin-off biotech company founded in Feb 2000 by Assoc. Prof. Lee Chee Wee of Department of Physiology, Faculty of Medicine. The company currently has 16 scientific staff and is equipped with numerous proprietary platform technologies such as (i) protein knock-out technology (drug discovery tool), (ii) biosurfactant technology (solvent-free chemical synthesis of sugar-based surfactants), (iii) transdermal drug delivery technology (unique lipovesicular-based high-loading system for delivering of hydrophilic molecules), and (iv) novel diagnostic technology (enhanced enzyme sensitivity and stability system). Assoc. Prof. Lee Chee Wee obtained his B.Sc. and M.Sc. from McGill University, Canada, and Ph.D. from University of Alberta, Canada, under the scholarship of Alberta Heritage Foundation for Medical Research. He was as a Postdoctoral Fellow at the Department of Pharmacology and Comprehensive Cancer Research Centre at Yale University School of Medicine prior his appointment with NUS in 1990. He is with the Department of Physiology ever since.
Registration
We are pleased to invite you and your colleagues to attend the talk. As there is limited number of seats available, please register for the talk by 8 July 2004 (noon). Please forward this invitation to your friends and colleagues who may be interested.
Admission is FREE & we look forward to seeing you at the seminar.
